We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Swimming Bio-Bots Designed to Traverse Biologic Aquatic Environments

By LabMedica International staff writers
Posted on 27 Jan 2014
Print article
Image: Engineers developed the first tiny, synthetic machines that can swim by themselves, powered by beating heart cells (Photo courtesy of Alex Jerez Roman, Beckman Institute for Advanced Science and Technology).
Image: Engineers developed the first tiny, synthetic machines that can swim by themselves, powered by beating heart cells (Photo courtesy of Alex Jerez Roman, Beckman Institute for Advanced Science and Technology).
Scientists have devised synthetic, tiny self-propelled swimming bio-bots that are able to move through the aquatic fluids of the body.

A team of engineers has developed a type of tiny bio-hybrid machines that swim similar to sperm, the first synthetic structures that can traverse the viscous fluids of biologic environments by themselves. A report on the study led by Taher Saif, a University of Illinois (I of U; Urbana-Champaign, USA) professor of mechanical science and engineering, was published on January 18, 2014, in the journal Nature Communications. “Microorganisms have a whole world that we only glimpse through the microscope,” Prof. Saif said. “This is the first time that an engineered system has reached this underworld.”

The engineers started by creating the body of the bio-bot from a flexible polymer. Then they cultured heart cells near the junction of the head and the tail. The cells self-align and synchronize to beat together, sending a wave down the tail that pushes the bio-bot forward.

This self-organization is an amazing new phenomenon, according to Prof. Saif; however, how the cells talk with each other on the flexible polymer tail is yet to be effectively determined. However, the cells need to beat together, in the right direction, for the tail to move. “It’s the minimal amount of engineering—just a head and a wire,” Prof. Saif said. “Then the cells come in, interact with the structure, and make it functional.”

The researchers also constructed two-tailed bots, which they found could swim even faster. Multiple tails also creates new avenues of navigation. The researchers foresee future bots that could sense or light or chemicals and move toward a target for medical or environmental applications. “The long-term vision is simple,” said Prof. Saif, who is also from the Beckman Institute for Advanced Science and Technology at the U of I. “Could we make elementary structures and seed them with stem cells that would differentiate into smart structures to deliver drugs, perform minimally invasive surgery or target cancer?”

The swimming bio-bot project is part of a larger US National Science Foundation-supported Science and Technology Center on Emergent Behaviors in Integrated Cellular Systems, which also produced the walking bio-bots developed at Illinois in 2012.

“The most intriguing aspect of this work is that it demonstrates the capability to use computational modeling in conjunction with biological design to optimize performance, or design entirely different types of swimming bio-bots,” said center director Dr. Roger Kamm, a professor of biological and mechanical engineering at the Massachusetts Institute of Technology (MIT; Cambridge MA, USA). “This opens the field up to a tremendous diversity of possibilities--truly an exciting advance.”

Related Links:

University of Illinois


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more